Form 8-K - Current report:
SEC Accession No. 0001104659-25-071928
Filing Date
2025-07-30
Accepted
2025-07-30 06:30:43
Documents
14
Period of Report
2025-07-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2522007d1_8k.htm   iXBRL 8-K 27487
2 EXHIBIT 99.1 tm2522007d1_ex99-1.htm EX-99.1 16698
6 GRAPHIC tm2522007d1_ex99-1img01.jpg GRAPHIC 3942
  Complete submission text file 0001104659-25-071928.txt   223745

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20250730.xsd EX-101.SCH 3032
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20250730_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20250730_pre.xml EX-101.PRE 22370
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2522007d1_8k_htm.xml XML 3832
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 251163865
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)